Log In
Print
BCIQ
Print
Print this Print this
 

Vimovo (formerly PN 400)

  Manage Alerts
Collapse Summary General Information
Company Pozen Inc.
DescriptionFixed-dose combination of 500 mg esomeprazole, a proton pump inhibitor (PPI) plus 20 mg naproxen
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$35.0M

$35.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today